Literature DB >> 6405081

[Benzodiazepines: significance of kinetics for therapy].

H R Ochs.   

Abstract

The onset and duration of action of benzodiazepines after single oral doses depend largely on absorption rate and the rate and extent of distribution. The rate and extent of accumulation during multiple dosage depend on elimination half-life and clearance. A framework is proposed for classification of benzodiazepines according to elimination half-life. Long acting benzodiazepines have half-life values usually exceeding 24 h. Drugs in this category have long-acting pharmacologically active metabolites, often desmethyldiazepam, accumulate extensively during multiple dosage, and may have impaired clearance in the elderly and those with liver disease. Intermediate and short-acting benzodiazepines have half-life values from 5-24 h and active metabolites are uncommon. Accumulation during multiple dosage is less extensive than with the long-acting group and diminishes as the half-life becomes shorter. Age and liver disease have a small influence on metabolic clearance. The half-life of ultrashort-acting benzodiazepines is less than 5 h. These drugs are essentially nonaccumulating. Pharmacokinetic classification may assist in understanding differences among benzodiazepines, but does not explain all of their clinical actions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405081     DOI: 10.1007/BF01496127

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  75 in total

1.  Effect of age on the pharmacokinetics of diazepam given in conjunction with spinal anesthesia.

Authors:  J Kanto; M Mäenpää; R Mäntylä; R Sellman; E Valovirta
Journal:  Anesthesiology       Date:  1979-08       Impact factor: 7.892

2.  Impairment of antipyrine metabolism by low-dose oral contraceptive steroids.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

3.  Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1982-01       Impact factor: 4.030

4.  Hypnotics: rebound insomnia and residual sequelae.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1980-03       Impact factor: 4.335

5.  Effect of age and gender on disposition of temazepam.

Authors:  M Divoll; D J Greenblatt; J S Harmatz; R I Shader
Journal:  J Pharm Sci       Date:  1981-10       Impact factor: 3.534

Review 6.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

7.  [Pharmacokinetics of midazolam in man (author's transl)].

Authors:  P M Lauven; H Stoeckel; H Ochs; D J Greenblatt
Journal:  Anaesthesist       Date:  1981-06       Impact factor: 1.041

8.  Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.

Authors:  A Kales; M B Scharf; J D Kales; C R Soldatos
Journal:  JAMA       Date:  1979-04-20       Impact factor: 56.272

9.  Effects of age and other drugs on benzodiazepine kinetics.

Authors:  D J Greenblatt; R I Shader
Journal:  Arzneimittelforschung       Date:  1980

Review 10.  Receptors for the age of anxiety: pharmacology of the benzodiazepines.

Authors:  J F Tallman; S M Paul; P Skolnick; D W Gallager
Journal:  Science       Date:  1980-01-18       Impact factor: 47.728

View more
  1 in total

1.  Influence of propranolol coadministration or cigarette smoking on the kinetics of desmethyldiazepam following intravenous clorazepate.

Authors:  H R Ochs; D J Greenblatt; A Locniskar; J Weinbrenner
Journal:  Klin Wochenschr       Date:  1986-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.